Shares of NuVasive, Inc. (NUVA) have traded between $45.6 – 81.92. The next earnings date is set for Feb 19, 2020. Let’s see how its prospects are shaping up.

What does NuVasive, Inc.(NUVA) do?

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

NUVA Insider Trading Insight

On 2020-01-16, Link Matthew Pres sold 3,000 shares of NUVA. That represents a value of $80,081. Not to be outdone, on 2019-12-24, Link Matthew S – Sale+OE sold3,500 shares of NUVA. These insiders are clearly in the know because they work closely with the company.

The GTT Consensus Price Target

The mean recommendation of GTT Communications, Inc. from top Wall Street analysts is a Moderate Buy. That is based on 3 analysts who work on the Street. Based on 3 analysts offering 12 month price targets for GTT Communications in the last 3 months. The average price target is $12.33 with a high forecast of $15.00 and a low forecast of $10.00. The average price target represents a -9.00% decrease from the last price of $13.55. Last week, several articles were published in financial papers about GTT and 33% Bearish while 67% Bullish.

GTT Intraday Trading

GTT is due to report earnings on Feb 27, 2020. In the last year the price has ranged from 4.68 – 43.35. Recently, Bruno S Joseph purchased 999 shares of GTT. He is a $6,676,723 shareholder in GTT.

Looking for stocks similar to NUVA and GTT?

Here are some stocks to consider:
OFIX
ZBH
FTR